Regional Cancer Care Associates Board Chairman Edward J. Licitra, MD, PhD, Elected to Community Oncology Alliance's Board of Directors

HACKENSACK, N.J., Jan. 10, 2017 /PRNewswire-USNewswire/ -- Edward J. Licitra, MD, PhD, Chairman of the Board of Directors of Regional Cancer Care Associates, or RCCA, has been elected to the board of the Community Oncology Alliance (COA), a nationwide, non-profit organization dedicated to ensuring that patients receive quality, affordable, and accessible cancer care in their own communities.

"I am honored to be joining the board of COA, a grassroots organization that does important work on behalf of cancer patients and the community-based physicians and practices who care for them," said Dr. Licitra, a medical oncologist who practices with the Central Jersey Division of RCCA, one of the nation's largest oncology-physician networks.

"Dr. Licitra will bring a great depth and breadth of experience to our board, and we look forward to drawing on his expertise," said Ted Okon, MBA, Executive Director of COA. Mr. Okon noted that in addition to being a practicing oncologist, an RCCA partner and Chairman of its board, Dr. Licitra serves as the Chief Financial Officer of the Central Jersey Division and the Medical Director of the RCCA Oral Pharmacy. "With the majority of Americans battling cancer receiving treatment in the community setting, it is imperative that the vitality of the community cancer care system be preserved, and Dr. Licitra's clinical, managerial, and fiscal acumen will be of considerable value as we pursue that goal," Mr. Okon added.

Terrill Jordan, President and Chief Executive Officer of RCCA, said, "We're delighted to see Dr. Licitra's contributions to outstanding community-based cancer care acknowledged by his election to the COA Board of Directors. As RCCA has grown to now encompass more than 100 oncologists treating every type of cancer at treatment centers in New Jersey, Maryland, Washington, DC, and Connecticut, we have maintained an unwavering focus on enabling cancer patients to receive the very latest therapies and compassionate care in convenient settings near their homes. Our mission is very much aligned with that of COA, and I know the insights that Dr. Licitra possesses by virtue of chairing the RCCA board will enable him to make great contributions to the Community Oncology Alliance."

Board-certified in internal medicine and medical oncology, Dr. Licitra received his PhD from the Massachusetts Institute of Technology (MIT) and his medical degree from the University of Medicine and Dentistry of New Jersey (UMDNJ) – Robert Wood Johnson Medical School. Following a residency at UMDNJ – Robert Wood Johnson, he completed his fellowship at the Cancer Institute of New Jersey. A member of the American Society of Clinical Oncology and the Medical Society of New Jersey, Dr. Licitra has been recognized as a "Top Doctor" by New Jersey Monthly magazine.

ABOUT COA

The Community Oncology Alliance (COA) is a non-profit organization dedicated to advocating for community oncology practices and, most importantly, the patients they serve. COA is the only organization dedicated solely to community oncology where the majority of Americans with cancer are treated. The mission of COA is to ensure that cancer patients receive quality, affordable, and accessible cancer care in their own communities. For more information, visit https://www.communityoncology.org.

ABOUT RCCA

Regional Cancer Care Associates (RCCA), one of the largest oncology physician networks in the United States, is transforming oncology care by ensuring that cancer patients have access to the highest-quality, most-comprehensive, cutting edge treatments in a compassionate and community-based setting. RCCA includes more than 100 cancer care specialists and is supported by 800 employees at 29 care delivery sites.  For more information visit: http://www.RCCA.com.

For further information, contact:

Bryan Soltes
[email protected]
201-510-0993

SOURCE Regional Cancer Care Associates